Plasma Metabolomic Profiling in 1391 Subjects with Overweight and Obesity from the SPHERE Study

Overview

Journal Metabolites

Publisher MDPI

Date 2021 Apr 3

PMID 33805234

Citations 14

Authors

Gianfranco Frigerio

Chiara Favero

Diego Savino

Rosa Mercadante

Benedetta Albetti

Laura Dioni

Luisella Vigna

Valentina Bollati

Angela Cecilia Pesatori

Silvia Fustinoni

Affiliations

Soon will be listed here.

Abstract

Overweight and obesity have high prevalence worldwide and assessing the metabolomic profile is a useful approach to study their related metabolic processes. In this study, we assessed the metabolomic profile of 1391 subjects affected by overweight and obesity, enrolled in the frame of the SPHERE study, using a validated LC-MS/MS targeted metabolomic approach determining a total of 188 endogenous metabolites. Multivariable censored linear regression Tobit models, correcting for age, sex, and smoking habits, showed that 83 metabolites were significantly influenced by body mass index (BMI). Among compounds with the highest association, aromatic and branched chain amino acids (in particular tyrosine, valine, isoleucine, and phenylalanine) increased with the increment of BMI, while some glycerophospholipids decreased, in particular some lysophosphatidylcholines (as lysoPC a C18:2) and several acylalkylphosphatidylcholines (as PC ae C36:2, PC ae C34:3, PC ae C34:2, and PC ae C40:6). The results of this investigation show that several endogenous metabolites are influenced by BMI, confirming the evidence with the strength of a large number of subjects, highlighting differences among subjects with different classes of obesity and showing unreported associations between BMI and different phosphatidylcholines.

Citing Articles

Clustering-Based Identification of BMI-Associated Metabolites with Mechanistic Insights from Network Analysis in Korean Men.

Park J, Kang J, Lee J, Kang D, Cho J, Choi J Metabolites. 2025; 15(2).

PMID: 39997714 PMC: 11857321. DOI: 10.3390/metabo15020088.

Metabolomics in juvenile idiopathic arthritis: A distinct profile in patients under methotrexate.

Tomioka R, Ferreira G, Aikawa N, Maciel G, Junior J, Baracat E Clinics (Sao Paulo). 2025; 80:100522.

PMID: 39879909 PMC: 11814531. DOI: 10.1016/j.clinsp.2024.100522.

Comparison of Adiposomal Lipids between Obese and Non-Obese Individuals.

Hussein M, Mirza I, Morsy M, Mostafa A, Hassan C, Masrur M Metabolites. 2024; 14(8).

PMID: 39195560 PMC: 11356626. DOI: 10.3390/metabo14080464.

Metabolomic profiling of Prader-Willi syndrome compared with essential obesity.

Rigamonti A, Polledri E, Favero C, Caroli D, Bondesan A, Grugni G Front Endocrinol (Lausanne). 2024; 15:1386265.

PMID: 38812813 PMC: 11133515. DOI: 10.3389/fendo.2024.1386265.

Metabolic liability for weight gain in early adulthood.

Murthy V, Mosley J, Perry A, Jacobs Jr D, Tanriverdi K, Zhao S Cell Rep Med. 2024; 5(5):101548.

PMID: 38703763 PMC: 11148768. DOI: 10.1016/j.xcrm.2024.101548.

References

Trabado S, Al-Salameh A, Croixmarie V, Masson P, Corruble E, Feve B . The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age. PLoS One. 2017; 12(3):e0173615. PMC: 5344496. DOI: 10.1371/journal.pone.0173615. View

Adams S . Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv Nutr. 2012; 2(6):445-56. PMC: 3226382. DOI: 10.3945/an.111.000737. View

Fucho R, Casals N, Serra D, Herrero L . Ceramides and mitochondrial fatty acid oxidation in obesity. FASEB J. 2016; 31(4):1263-1272. DOI: 10.1096/fj.201601156R. View

Lent-Schochet D, McLaughlin M, Ramakrishnan N, Jialal I . Exploratory metabolomics of metabolic syndrome: A status report. World J Diabetes. 2019; 10(1):23-36. PMC: 6347655. DOI: 10.4239/wjd.v10.i1.23. View

Bagheri M, Djazayery A, Farzadfar F, Qi L, Yekaninejad M, Aslibekyan S . Plasma metabolomic profiling of amino acids and polar lipids in Iranian obese adults. Lipids Health Dis. 2019; 18(1):94. PMC: 6456979. DOI: 10.1186/s12944-019-1037-0. View

Yu H, Fu X, Xu B, Zuo L, Ma H, Wang S . Untargeted metabolomics approach (UPLC-Q-TOF-MS) explores the biomarkers of serum and urine in overweight/obese young men. Asia Pac J Clin Nutr. 2018; 27(5):1067-1076. DOI: 10.6133/apjcn.052018.07. View

Muller G, Tschop M, Muller T . Upregulated phospholipase D activity toward glycosylphosphatidylinositol-anchored proteins in micelle-like serum complexes in metabolically deranged rats and humans. Am J Physiol Endocrinol Metab. 2020; 318(4):E462-E479. DOI: 10.1152/ajpendo.00504.2019. View

Cirulli E, Guo L, Swisher C, Shah N, Huang L, Napier L . Profound Perturbation of the Metabolome in Obesity Is Associated with Health Risk. Cell Metab. 2018; 29(2):488-500.e2. PMC: 6370944. DOI: 10.1016/j.cmet.2018.09.022. View

Bollati V, Iodice S, Favero C, Angelici L, Albetti B, Cacace R . Susceptibility to particle health effects, miRNA and exosomes: rationale and study protocol of the SPHERE study. BMC Public Health. 2014; 14:1137. PMC: 4242553. DOI: 10.1186/1471-2458-14-1137. View

10.

Muller G, Herling A, Stemmer K, Lechner A, Tschop M . Chip-based sensing for release of unprocessed cell surface proteins in vitro and in serum and its (patho)physiological relevance. Am J Physiol Endocrinol Metab. 2019; 317(2):E212-E233. DOI: 10.1152/ajpendo.00079.2019. View

11.

Libert D, Nowacki A, Natowicz M . Metabolomic analysis of obesity, metabolic syndrome, and type 2 diabetes: amino acid and acylcarnitine levels change along a spectrum of metabolic wellness. PeerJ. 2018; 6:e5410. PMC: 6120443. DOI: 10.7717/peerj.5410. View

12.

Rubino F, Puhl R, Cummings D, Eckel R, Ryan D, Mechanick J . Joint international consensus statement for ending stigma of obesity. Nat Med. 2020; 26(4):485-497. PMC: 7154011. DOI: 10.1038/s41591-020-0803-x. View

13.

Tulipani S, Palau-Rodriguez M, Minarro Alonso A, Cardona F, Marco-Ramell A, Zonja B . Biomarkers of Morbid Obesity and Prediabetes by Metabolomic Profiling of Human Discordant Phenotypes. Clin Chim Acta. 2016; 463:53-61. DOI: 10.1016/j.cca.2016.10.005. View

14.

Vignoli A, Tenori L, Luchinat C, Saccenti E . Age and Sex Effects on Plasma Metabolite Association Networks in Healthy Subjects. J Proteome Res. 2017; 17(1):97-107. DOI: 10.1021/acs.jproteome.7b00404. View

15.

Xie G, Ma X, Zhao A, Wang C, Zhang Y, Nieman D . The metabolite profiles of the obese population are gender-dependent. J Proteome Res. 2014; 13(9):4062-73. PMC: 6098236. DOI: 10.1021/pr500434s. View

16.

Kim O, Lee J, Sweeney G . Metabolomic profiling as a useful tool for diagnosis and treatment of chronic disease: focus on obesity, diabetes and cardiovascular diseases. Expert Rev Cardiovasc Ther. 2012; 11(1):61-8. DOI: 10.1586/erc.12.121. View

17.

Maltais-Payette I, Boulet M, Prehn C, Adamski J, Tchernof A . Circulating glutamate concentration as a biomarker of visceral obesity and associated metabolic alterations. Nutr Metab (Lond). 2018; 15:78. PMC: 6219091. DOI: 10.1186/s12986-018-0316-5. View

18.

Xie B, Waters M, Schirra H . Investigating potential mechanisms of obesity by metabolomics. J Biomed Biotechnol. 2012; 2012:805683. PMC: 3362137. DOI: 10.1155/2012/805683. View

19.

Wang S, Yang R, Wang M, Ji F, Li H, Tang Y . Identification of serum metabolites associated with obesity and traditional risk factors for metabolic disease in Chinese adults. Nutr Metab Cardiovasc Dis. 2017; 28(2):112-118. DOI: 10.1016/j.numecd.2017.09.009. View

20.

Zhao X, Han Q, Liu Y, Sun C, Gang X, Wang G . The Relationship between Branched-Chain Amino Acid Related Metabolomic Signature and Insulin Resistance: A Systematic Review. J Diabetes Res. 2016; 2016:2794591. PMC: 5014958. DOI: 10.1155/2016/2794591. View